✦ LIBER ✦

BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line

✍ Scribed by Tsutomu Kawasaki; Sana Yokoi; Hitoshi Tsuda; Hiroyuki Izumi; Ken-ichi Kozaki; Shinsuke Aida; Yuichi Ozeki; Yasuyuki Yoshizawa; Issei Imoto; Johji Inazawa

Book ID: 108583905
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 326 KB
Volume: 98
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2007.00491.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TAZ is a novel oncogene in non-small cel

TAZ is a novel oncogene in non-small cell lung cancer

✍ Zhou, Z; Hao, Y; Liu, N; Raptis, L; Tsao, M-S; Yang, X 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 375 KB

Apoptosis by gemcitabine in non-small ce

Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase

✍ R. Kurdow; B. Schniewind; S. Zoefelt; L. Boenicke; A.-S. Boehle; P. Dohrmann; H. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 236 KB

RhoB is frequently downregulated in non-

RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line

✍ Naohito Sato; Takayuki Fukui; Tetsuo Taniguchi; Toshihiko Yokoyama; Masashi Kond 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 477 KB

## Abstract Identification of a homozygous deletion in cancer cells provides strong evidence for the location of a tumor suppressor gene (TSG). We analyzed the 2p24 homozygous deletion of a non‐small‐cell lung cancer (NSCLC) cell line, NCI‐H2882, and found that the deletion size was 3.7 Mbp. Since

Mcl-1 is critical for survival in a subg

Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines

✍ Zhang, H; Guttikonda, S; Roberts, L; Uziel, T; Semizarov, D; Elmore, S W; Levers 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 412 KB

EGFR point mutation in non-small cell lu

EGFR point mutation in non-small cell lung cancer is occasionally accompanied by a second mutation or amplification

✍ Toshihiko Yokoyama; Masashi Kondo; Yasuhiro Goto; Takayuki Fukui; Hiromu Yoshiok 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Identification of SMURF1 as a possible t

Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization

✍ Ayako Suzuki; Tatsuhiro Shibata; Yutaka Shimada; Yoshinori Murakami; Akira Horii 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB